Literature DB >> 10214811

Speech perception of young children using nucleus 22-channel or CLARION cochlear implants.

N M Young1, K M Grohne, V N Carrasco, C Brown.   

Abstract

This study compares the auditory perceptual skill development of 23 congenitally deaf children who received the Nucleus 22-channel cochlear implant with the SPEAK speech coding strategy, and 20 children who received the CLARION Multi-Strategy Cochlear Implant with the Continuous Interleaved Sampler (CIS) speech coding strategy. All were under 5 years old at implantation. Preimplantation, there were no significant differences between the groups in age, length of hearing aid use, or communication mode. Auditory skills were assessed at 6 months and 12 months after implantation. Postimplantation, the mean scores on all speech perception tests were higher for the Clarion group. These differences were statistically significant for the pattern perception and monosyllable subtests of the Early Speech Perception battery at 6 months, and for the Glendonald Auditory Screening Procedure at 12 months. Multiple regression analysis revealed that device type accounted for the greatest variance in performance after 12 months of implant use. We conclude that children using the CIS strategy implemented in the Clarion implant may develop better auditory perceptual skills during the first year postimplantation than children using the SPEAK strategy with the Nucleus device.

Entities:  

Mesh:

Year:  1999        PMID: 10214811     DOI: 10.1177/00034894991080s420

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  2 in total

1.  Exploring the language and literacy outcomes of pediatric cochlear implant users.

Authors:  Linda J Spencer; Brittan A Barker; J Bruce Tomblin
Journal:  Ear Hear       Date:  2003-06       Impact factor: 3.570

Review 2.  Current trends in outcome studies for children with hearing loss and the need to establish a comprehensive framework of measuring outcomes in children with hearing loss in China.

Authors:  Xueman Liu
Journal:  J Otol       Date:  2016-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.